Ideaya Biosciences Inc (IDYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 34,067 | 20,505 | 0 | N/A | N/A |
| Marketable Securities | 64,889 | 69,456 | 0 | N/A | N/A |
| TOTAL | $101,654 | $90,667 | $0 | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 4,642 | 5,152 | 0 | N/A | N/A |
| Investments And Advances | 1,526 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 5,179 | 722 | 0 | 0 | 0 |
| TOTAL | $11,347 | $5,874 | $N/A | $N/A | $N/A |
| Total Assets | $113,001 | $96,541 | $0 | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 709 | 1,417 | 0 | 0 | 0 |
| Accrued Expenses | 5,023 | 3,583 | 0 | N/A | N/A |
| Other current liabilities | 63 | 114 | 0 | N/A | N/A |
| TOTAL | $6,940 | $5,413 | $0 | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | 299 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 5,661 | 138,504 | 0 | 0 | 0 |
| TOTAL | $5,661 | $140,076 | $N/A | $N/A | $N/A |
| Total Liabilities | $12,601 | $145,489 | $0 | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 20,344 | N/A | N/A | N/A | N/A |
| Common Shares | 2 | N/A | 0 | N/A | N/A |
| Retained earnings | -92,491 | -50,516 | 0 | N/A | N/A |
| Other shareholders' equity | 65 | -31 | 0 | 0 | 0 |
| TOTAL | $100,400 | $-48,948 | $0 | $N/A | $N/A |
| Total Liabilities And Equity | $113,001 | $96,541 | $0 | $0 | $0 |